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Summary Proteoglycans (PGs) were localised immunohistochemically in 52 salivary gland tumours including
pleomorphic adenoma, adenoid cystic carcinoma, acinic cell carcinoma, oncocytoma, mucoepidermoid car-
cinoma, clear cell tumour and Warthin tumour, using antibodies raised against large PG, small PG,
chondroitin 4-sulphate PG, chondroitin 6-sulphate PG, heparan sulphate PG and keratan sulphate PG. Large
PGs were mainly observed in mucinous materials ofextracellular matrix (ECM) and interstitial fibrous element
of tumour tissues, while small PGs were located only in hyaline matrix and surrounding fibrous (capsular)
connective tissues. Chondroitin 6-sulphate PG was detected in the ECM of pleomorphic adenomas and clear
cell carcinomas and in pseudocystic spaces of adenoid cystic carcinomas, but only in vessel walls in
non-neoplastic tissues. Keratan sulphate PG was observed to locate in mucinous material of pleomorphic
adenomas, acinic cell carcinomas and clear cell carcinomas, but not in the adenoid cystic carcinomas
examined, and it was also unobservable in non-neoplastic salivary gland tissues. Heparan sulphate PG was
observed on the inner surfaces of true ductal spaces of adenoid cystic carcinomas and on cell surfaces of
oncocytoma cells. By HPLC analysis, individual glycosaminoglycans contained in tumour tissues were com-
pared. Chondroitin 6-sulphate PG was very rich in ECM of pleomorphic adenomas and adenoid cystic
carcinomas. Pleomorphic adenomas contained relatively more low-sulphated chondroitin sulphate than
adenoid cystic carcinomas and other tumours.
The most characteristic feature of salivary gland tumours is
the presence of a significant amount of extracellular matrix
(ECM) consisting of proteoglycan (PG) and other glyco-
proteins. It is well known that the myxomatous areas in
pleomorphic adenoma contain a large amount of mucinous
substances which are mainly composed of PG. Adenoid cys-
tic carcinomas characteristically shows many pseudocystic
spaces which also contain a large amount ofPG. Biochemical
analysis and histochemical studies of ECM components in
the salivary gland tumours have been performed (Lovell et
al., 1966; Takeuchi et al., 1975, 1976, 1978; Toida et al.,
1985), but the precise localisation of individual PG-com-
ponents have not been thoroughly elucidated.
PGs are macromolecules composed of a core protein to
which one or more glycosaminoglycan (GAG) side chains are
covalently linked. These molecules are major components of
the ECM and comprise a large family, in which individual
differences can be noted in the chemical nature of core
proteins and GAG-side chains. Recently, PGs have been
divided into two families, small and large (Heinegard &
Sommarin, 1987). The small PGs, consisting of Mr 43,000-
45,000 core molecules, have been purified from various tis-
sues (Coster & Franson, 1981; Damle et al., 1982; Vogel &
Heinegard et al., 1985; Sobue et al., 1987a). Monoclonal
antibodies have been produced against the small PG by a
number of investigators (Poole et al., 1986; Voss et al., 1986;
Sobue et al., 1988). The immunohistochemical localisation of
the small PG families has been widely noted in the ECM of
various human tissues (Sobue et al., 1987b 1988). As for the
large PG family, non-aggregating large chondroitin sulphate
PG with Mr of 1 x 106-2.5 x 106 has been detected in meta-
physes, skeletal muscle, skin and tumour tissues (Fisher et
al., 1983; Heinegard et al., 1985; Sobue et al., 1987a, 1989a).
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Recently, we produced a monoclonal antibody (2B1) raised
against large PG purified from a human yolk sac tumour
(Sobue et al., 1989a), and monoclonal antibody 6B6, which
reacts specifically with small PG purified from ovarian
fibroma capsule (Sobue et al., 1988). Couchman et al. (1984)
produced antibodies 9A2 and 3B3 which were raised against
a stub of A Di-4S and A Di-6S unit binding to a core protein
by a linkage tetrasaccharide obtained from chondroitin sul-
phate PG by chondroitinase ABC-treatment. Using these
antibodies, Couchman et al. (1984) demonstrated immuno-
histochemically a specific and distinctive distribution ofchon-
droitin 4- or 6-sulphate PG in different connective tissues.
In the present study, in order to clarify the histogenesis
and biological characteristics of each salivary gland tumour,
ECM components produced by tumour cells were character-
ised immunohistochemically using the antibodies against
large PG, small PG, chondroitin 4- or 6-sulphate PG,
heparan sulphate PG and keratan sulphate PG. The specific
and distinctive ECM components were found to be charac-
teristic of each type of salivary gland tumour. Individual
GAGs were also examined in some tumour tissues by HPLC
analysis after digestion with GAG-degrading enzymes.
Materials and methods
Tissues
The salivary gland tumour tissues examined in the present
study were: 30 pleomorphic adenomas, six adenoid cycstic
carcinomas, five clear cell tumours, four mucoepidermoid
tumours, two acinic cell tumours, three papillary cyst-
adenoma lymphomatosum (Warthin tumour) and two oxy-
philic adenomas (oncocytomas). Three cases of chronic
sialadenitis were also investigated. These specimens were
obtained from biopsies at Nagoya University Hospital.
Tissue slices approximately 3 mm thick were cut from the
excised tissues, and fixed in glacial acetic acid 1% (v/v) in
95% ethanol (Sainte-Marie, 1962) at 4°C for 12-24 h. The
specimens were then dehydrated in an ethanol series of
ascending concentrations, embedded in paraffin wax, and
sectioned at a thickness of 4itm.
Br. J. Cancer (I991), 64, 307 314 'PI Macmillan Press Ltd., 1991308 Y. NARA et al.
Antibodies
The antibodies used in the present study were: (1) mono-
clonal antibodies 9A2 (against a stub of A Di-4S unit binding
to core protein obtained from chondroitin sulphate PG by
chondroitinase ABC) and 3B3 (against a stub of A Di-6S
unit binding to core protein obtained from chondroitin sul-
phate PG by chondroitinase ABC) (Couchman et al., 1984);
(2) monoclonal antibody 6B6 against the core protein of
dermatan sulphate and chondroitin sulphate small PG, which
was purified from the capsular tissue of a human ovarian
fibroma (Sobue et al., 1987a, 1988); (3) monoclonal antibody
2B1 against the core protein of chondroitin sulphate large
PG purified from a human yolk sac tumour (Sobue et al.,
1989a); (4) monoclonal antibody CS56, which reacts with
chondroitin sulphate, but not with dermatan sulphate (Avnur
& Geiger, 1984); (5) monoclonal antibody HepSS-1 against
heparan sulphate PG purified from murine fibrosarcoma cells
(Kure & Yoshie, 1986); (6) monoclonal antibody 5D4 against
keratan sulphate which is linked to PG core protein isolated
after chondrioitinase ABC digestion of human articular car-
tilage PG monomer (Caterson et al., 1983); (7) goat antisera
against type I and IV collagens (Southern biotechnology
Associates Inc., Birmingham, Al., USA); (8) rabbit antiserum
against laminin (E-Y Laboratories, San Mateo, Ca., USA),
fibronectin (Cappel Laboratories, West Chester, Pa., USA),
and elastin (Elastin Products Company Inc., Pacific, Mo.,
USA). The antiserum against elastin which was produced in
our laboratory (Sobue et al., 1987b) was also used.
The antibodies 2B1, 6B6, 9A2, 3B3, HepSS-1, CS56 and
5D4 were obtained from Seikagaku Corporation, Tokyo. The
antibody 9A2 is called '2B6' at present.
Staining procedures
For the staining of antigen for 2B1, antigen for CS56 and
antigen for HepSS-1, the deparaffinised tissue sections were
pretreated with trypsin (Worthington Diagnostic Systems,
USA) at a concentration of 5-10 fig ml-' in 0.01 M phos-
phate buffered saline (0.8% NaCI) (PBS) (37°C, 30 min). For
the staining of type I and IV collagens, pronase (Kaken
Seiyaku Co., Ltd., Tokyo, Japan) was substituted for trypsin
at a concentration of 25-50 fg ml-' in PBS (37°C, 20 min).
For the staining of antigens for 9A2, 3B3, 6B6 and 5D4, the
deparaffinised tissue sections were pretreated with chondroi-
tinase ABC (Seikagaku Corporation, Tokyo). The digestion
with chondroitinase ABC was done with 0.2 U ml-' of the
enzyme in 20 mM Tris-HCI (pH 8.0), containig 20 mM acetic
acid and a series of protease inhibitors, as reported by Oike
et al. (1980). The enzyme digestion was performed at 37°C
for 1 h.
All the enzyme-treated sections were washed in PBS, soak-
ed in methanol containing 0.3% (v/v) H202 to inhibit the
activity of endogenous peroxidase, washed with PBS, and
then allowed to react with normal goat (or rabbit) serum
(1:100 dilution) for 20 min, followed by reaction with a
diluted culture fluid (1:1,000-5,000) containing monoclonal
antibodies 9A2, 3B3, 6B6, 2B1, HepSS-1, 5D4 or with rabbit
antiserum to laminin (1:1,000 dilution), fibronectin (1:3,000),
elastin (1:1,000), or with goat antisera to type 1 (1:200) and
IV (1:2,000) collagens. One hour after reaction with an anti-
body at room temperature, excess antibody was removed
from the tissue sections by washing with PBS. The bound
antibodies were subsequently labelled with biotinylated anti-
mouse immunoglobulin or with biotinylated anti rabbit (or
anti goat) immunoglobulin and peroxidase-conjugated strep-
tavidin (StrAviGen B-SA immunostaining kits, BioGENEX
Lab, Dublin, Ca., USA). After washing with PBS, tissue
sections were incubated in 0.05 M sodium acetate-acetic acid
buffer (pH 5.0) containing 0.02% (w/v) 3-amino 9-ethyl-
carbozole and 0.014% (w/v) H202, and allowed to react for
5- 10 min.
Sections were finally counterstained with haematoxylin,
and embedded in glycerin gelatin solution (glycerin : 20%
gelatin solution = 1:1). As controls for staining with anti-
bodies 9A2, 3B3 and 6B6, chondroitinase ABC-untreated
tissue sections were employed. Positive controls for 2B1-
staining were sections of the original tumours tissue (yolk sac
tumour) (Nakashima et al., 1990). As negative controls, nor-
mal mouse or rabbit serum was employed for the reaction
instead of primary antibodies.
The specificity of 5D4-staining for keratan sulphate was
confirmed by pre-digestion with keratanase II (100 mU ml-',
10 mM acetate buffer, pH 6.5, 37°C, 1 h).
Biochemical analysis ofglycosaminoglycan (GAG)
Isolation of crude GAG from tumour tissues An adenoid
cystic carcinoma, two pleomorphic adenomas, a clear cell
carcinoma and an oncocytoma were used for analysis. Imme-
diately after surgical excision, the tumour tissues were cut
into many slices, and the small pieces were acetone-dried.
The resulting dry powder was weighed and suspended in
0.3 M NaOH and kept at 4°C overnight. It was then neutra-
lised with 6M HCI, adjusted with 1 M Tris-HCl buffer, and
digested with pronase (50 mg ml-') at 50°C, for 5 h. The
pronase-digestion was repeated, and the undigested materials
were discarded by centrifugation, and the supernatant fluid
was collected and dialysed against distilled water at 4°C
overnight. Then, the fluid was treated with RNAase (1 mg
ml , pH 7.2 adjusted with Tris-HCl buffer) at 37°C for 2 h,
and with DNAase (1 mg ml-', with 0.1 M MgCl2) at 37°C for
5-8 h. Afterwards, crude GAG was precipitated with 0.20
volume of 1% cetylpyridinium chloride (CPC) solution in the
presence of 0.03 M NaCl. The CPC-GAG complex formed
was then washed with 0.2% CPC solution in the presence of
0.03 M NaCl. The precipitate was dissolved in 3 M NaCl
solution, and was added with three volumes of 95% aqueous
ethanol containing 1% potassium acetate. The precipitate
formed was washed with I ml of 95% aqueous ethanol con-
taining 1% potassium acetate twice, with 80% aqueous
ethenol, and with acetone, and dried.
Fractionation of crude GAG Crude GAG isolated from each
tumour tissue by the method described above was dissolved
in 0.3 M NaCl, and applied to an anion-exchange column
(DIAION HPA-0.8 x 5 cm) equilibrated with 0.3 M NaCl.
The column was washed with 0.3 M NaCl and eluted sequen-
tially with 0.5 M, 1.25 M, 1.6 M and 3.0 M NaCl. Each frac-
tion was desalted on the column of cellulofine GCL-25, and
dried and dissolved in distilled water.
Analytical methods (a) Estimation ofGAG The contents of
hyaluronic acid, chondroitin sulphate and heparan sulphate
were estimated as uronic acid using the method of Bitter and
Muir (1962). The components of individual GAGs were
obtained by the susceptibility to the specific GAG-degrading
enzymes, chondroitinases ABC and ACII and heparitinases I
and II. Keratan sulphate was estimated from the amount of
oligosaccharide produced by keratanase II-digestion of 3.0 M-
fraction. In general, GAGs are completely precipitated by
CPC, but keratan sulphate is considered poorly precipitated.
Therefore, the measurement of keratan sulphate only detect-
ed a part of the keratan sulphate contained in the tissues,
since non-precipitated keratan sulphate was not measured in
the present study. (b) Enzymatic degradation About 100pg of
each GAG-fraction was incubated with the following
enzymes for 2 h at 37°C: Chondroitinase ACII (0.2 U in
50mM sodium acetate buffer, pH 7.0); chondroitinase ABC
(0.5 U in 50 mM Tris-HCI buffer, pH 7.9; heparitinases I and
II (each 20 mU in 20mM acetate buffer, pH 7.0, containing
2 M calcium acetate); keratanase II (20 mU in acetate buffer,
pH 6.0). These enzymes were products of Seikagaku Corpor-
ation, Tokyo. (c) Analysis of High Performance Liquid
Chromatography. Gel permeation chromatography was per-
formed using a column, TSK gel (G2500 + G3000 + G4000)
PWXL (TOSO Co.). About 40flI of each fraction with and
without each enzyme was chromatographed on the column
with 0.2 MNaCl, and monitored by RI and UV (230) detec-
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Anion-exchange HPLC of the chondroitinase ABC or AC
II digests was done by the method of Yoshida et al. (1989).
The disaccharide composition (A& Di-OS, Di-6S or A Di-
4S) was calculated from UV absorbance.
Results
Immunohistochemistry
The results of immunohistochemical studies on each distinct
area in seven kinds of salivary gland tumours examined are
summarised in Table I.
Pleomorphic adenoma
The various histological features are observed in different
parts of the same tumour. Two types of cells, inner epithelial
cells and outer myoepithelial cells, form glands, tubules, solid
nests and ribbons. The ECM consists of varying admixtures
of mucoid, myxomatous, chondroid and hyaline patterns.
The majority of myxomatous areas are reactive to anti-
bodies 2B1 and 3B3 (Figure 1 a-d). Some parts, mainly
somewhat hyalinous areas, are stained with 9A2 (Figure 1f).
The cell nests of spindle cells were strongly positive with
antibody 3B3 (Figure ld). The positive reaction to 6B6 was
observed only in some hyalinous connective tissue separating
and surrounding tumour cell nests (Figure le).
It was most interesting that the mucoid and myxoid areas
were positive with antibody 5D4 (Figure 1 g and h). The
5D4-positive material was abolished by pre-treatment with
keratanase II. Some spindle cell nests were especially reactive,
and cell surface or intercellular elements were strongly posi-
tive with 5D4 (Figure lh), but non-neoplastic portions were
thoroughly negative (Figure 7c).
Adenoid cystic carcinoma
Small basal-like tumour cells are arranged in cylindromatous,
cribriform, solid and tubular patterns. Numerous pseudocys-
tic spaces containing mucinous materials are observed.
The mucinous materials in the pseudocystic spaces were
stained with antibodies 2B1 and 3B3 (Figure 2 a and c), but
not with 9A2 and 6B6. When they were replaced by hyalin-
ised fibrous materials, the spaces were, however, reactive with
antibodies 9A2 but not with 2B1 and 3B3. The surrounding
stromal elements were usually stained with 9A2 and 6B6
(Figure 2b) but not with 2B1 and 3B3.
Neither pseudocystic spaces nor the stromal elements were
reactive to antibody 5D4, though most stromal areas of
pleomorphic adenomas were strongly positive with 5D4.
As shown in Figure 2d, the inner surface of some small
cystic spaces, which were largely true ductal spaces, were
clearly stained with antibody HepSS-1. The inner surface of
pseudocystic space was linearly positive with antibody
against type IV collagen (Figure 2e), and the 2B1 and 3B3-
reactive elements in the pseudocystic spaces were also posi-
tively stained with antibody against laminin (2f).
Mucoepidermoid carcinoma
This tumour is composed of varying proportions of mucous-
secreting cells, squamous cells and intermediate cells. Most of
the cases examined in the present study are high grade car-
cinoma which form solid nests composed of epidermoid cells
with a few mucin-producing elements. Proliferation of inter-
stitial fibrous connective tissues is observed.
These interstitial fibrous elements were positively stained
with antibody 2BI (Figure 3a) and 9A2, and some highly
collagenised tissues, which had considerably pre-existed
before the tumour-invasion, were reactive to 6B6 (Figure 3b).
The few mucin-producing cells were positive with antibody
5D4 (Figure 3c). Epideroid cells themselves were not stained
with any antibodies.
Clear cell carcinoma (carcinoma ofintercalated ducts)
This tumour is composed basically of two cell layers, inner
small ductal cells and outer clear cells. Eosinophilic basement
membrane-like elements surround the tumour cell nests.
The basement membrane-like materials were stained not
only with 2B1 and 3B3 (Figure 4 a and b), but also with 9A2
and 5D4. These were also stained with type IV collagen
(Figure 4c) and laminin (Figure 4d).
Acinic cell tumour
The round to polygonal cells with granular cytoplasm inter-
mingled with clear cells grow in a lobular or solid pattern.
All tumour cells were intensely positive with 5D4 (Figure 5),
though non-neoplastic acinic or tubular cells were throughly
negative. Interstitial elements of tumour cells were reactive to
2B1 and 3B3, which were not stained in tumour cells.
Table I Stainability with antibodies
Tumours (No. oftumours) 2B1 6B6 3B3 9A2 CS Hep 5D4 IV LM FN EL
Pleomorphic adenoma (30)
myxomatous areas and mucoid cells + - + ± + - + + + - +
hyalinous areas - + - - - - - + - +
Adenoid cystic carcinomas (6)
ECM in pseudocystic space + - + - + - - - + + -
inner surface of pseudocystic space + - + - + - - + + + -
outer surface ofpseudocystic space + - + - + - - + + + -
interstitial elements - + - + - - - - - + -
inner surface of true ductal spaces - - - - - +
Mucoepidermoid carcinoma (4)
interstitial fibrous elements
loose connective tissue + - - - + - - - - +
hyalinous connective tissue - + - + + - _ _ +
Clear cell carcinoma (5)
eosinophilic ECM + - + + + - + +
Acinic cell carcinoma (2)
intracellular mucinous material - - - - - - +
interstitial fibrous elements + + - - + - + + + + ±
Oncocytoma (2)
cell surfaces and intracellular + - - - - -
Warthin tumour
epithelial tumour cells + - - - - -
fine fibrillar elements +
+, positive stain; -, no reaction with; ±, occasionally reactive. CS: CS56, Hep: HepSS-l, IV: Type IV collagen, LM:
laminin, FN: fibronectin, EL: elastin.310 Y. NARA et al.
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Figure 1 Immunostaining with antibodies against proteoglycan in pleomorphic adenoma. a and b are stained with 2B1 (x 150 and
x 300), c and d stained with 3B3 (x 150 and x 300), e stained with 6B6 (x 75), f stained with 9A2 (x 150), g and h stained with 5D4 (x 150 and x 300) (Counterstained with haematoxylin). ECM of myxomatous areas is positively stained with 2B1 and 3B3. Only fibrous connective tissue is reactive to 6B6. Somewhat hyaline material in ECM is reactive to 9A2. ECM and cell surfaces are positive with 5D4.
Oxyphilic adenoma
Tumour cells, containing oxyphilic fine granules, were not
reactive to any antibodies 2B1, 3B3, 9A2, 6B6, CS56 and
5D4, but the tumour cell surface and cytoplasm were stained
with antibody HepSS-1 (Figure 6). The interstitial fibrous
elements were stained with 2B1 and 9A2.
Warthin tumour
The epithelial tumour cells, having eosinophilic cytoplasm,
were stained with HepSS-1. The interstitial fine fibrous ele-
ment was positive to antibody 2B1.
Sialadenitis
Acinic cells and tubular cells were not reactive to any anti-
bodies against PGs. Periductal fibrous elements (only thin
layers) were reactive to 2B1 (Figure 7a), and the interlobular
fibrous connective tissues were stained with 6B6 (Figure 7b)
and 9A2. Only vessel walls were stained with 3B3, and
peri-vascular elements were positive with 9A2. In some areas,
the sebaceous metaplasia was observed, and the cell surface
of sebaceous cells was stained with HepSS-l. 5D4-reactive
elements could not be observed (Figure 7c).
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Figure 2 Immunostaining of adenoid cystic carcinoma. a is stained with 2B1, b stained with 6B6 and c stained with 3B3 (x 150). d is stained with HepSS-l, e stained for type IV collagen and f stained for laminin (x 300) (Counterstained with haematoxylin). The mucinous material in the pseudocystic spaces is reactive to 2B1 and 3B3 but not to 6B6. The 6B6-positive reaction is seen in the
outer stromal areas. The inner surfaces of ductal spaces are stained with HepSS-1. Positive stainings of type IV collagen and laminin are visible in the inner surfaces of pseudocystic spaces.
b
C
Figure 3 Immunostaining of mucoepidermoid carcinoma. a is stained with 2B1, and b stained with 6B6 (x 150). c is stained with 5D4 (x 300) (Counterstained with haematoxylin). The interstitial fibrous elements consisting of loose connective tissue are positive with 2B1, whereas much collagenised (pre-existing) connective tissue is reactive to 6B6. Mucinous material in the tumour cells is reactive to 5D4.
Biochemical analysis ofGAG by ion-exchange column and
HPLC
Two pleomorphic adenomas, one clear cell adenoma, one
adenoid cystic carcinoma, and one oncocytoma were analys-
ed. Figure 8 shows GAG-components in each tumour tissue
which were determined by uronic acid content and suscepti-
bility to GAG-degrading enzymes. A larger amount of chon-
droitin sulphate was detected in pleomorphic adenoma and
adenoid cystic carcinoma. Clear cell carcinoma contained a
relatively larger amount of heparan sulphate and hyaluronic
acid. Much more keratan sulphate was detected in adenoid
cystic carcinoma tissue, though it was not detectable by
immunohistochemical technique as described above. In the
cases of pleomorphic adenoma, much more chondroitin sul-
phate was detected in 1.25 M fraction than in 1.6 M fraction,
a
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Figure 5 Immunostaining with 5D4 in acinic cell carcinoma
(Counterstained with haematoxylin, x 150). Intracellular mucin-
ous material is strongly positive.
Figure 6 Immunostaining with HepSS-1 in oxyphilic adenoma
(Counterstained with haematoxylin, x 150). The cell surfaces and
cytoplasm of tumour cells are reactive.
a
b
d
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Figure 4 Immunostaining of clear cell carcinoma. a is stained
with 2B1, b stained with 3B3, c stained for type IV collagen and
d stained for laminin (Counterstained with haematoxylin, x 150).
The ECM is reactive to 2BI and 3B3. Type IV collagen and
laminin are also stained.
Figure 7 Immunostaining of sialoadenitis. a is stained with 2B1,
b stained with 6B6 and c stained with 5D4 (Counterstained
with haematoxylin, x 75). The interstitial elements are positive
with 2B1 a, but only surrounding connective tissues are stained
with 6B6 b. The 5D4-staining is negative in non-neoplastic tissue c.
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Pleo 1
Pleo2
AdCC
Oncc
Oncol
0 5
Uronic acid or Galactose (mg g- of dry tissue)
Figure 8 GAG-components in each tumour tissue. The contents
of glycosaminoglycuronon were shown as uronic acid. The con-
tent of keratan sulphate was shown as galactose. L: Hyal-
uronic acid; 13I: Heparan sulfate; ME: Dermatan sulfate;
l: Chondroitin sulfate; M: Keratan sulfate; Pleo: Pleomor-
phic adenoma; AdCC: Adenoid cystic carcinoma; CICC: Clear
cell carcinoma; Onco: oncocytoma.
but it was less in 1.25 M fraction of other tumours. This
suggests that pleomorphic adenomas contain more low-sul-
phated chondroitin sulphate than adenoid cystic carcinoma
or other tumours. Table II indicates the disaccharide
composition of GAG fractions which were determined by
anion-exchange HPLC after chondroitinase AC II-digestion.
Chondroitin 6-sulphate was rich in pleomorphic adenoma
and adenoid cystic carcinoma.
Discussion
The antibodies 3B3 and 9A2 react with stubs of chondroitin
4- and 6-sulphate left attached to core protein, respectively,
which are generated from the chondroitin sulphate chains by
digestion with chondroitinase ABC. These antibodies do not
recognise the entire consistency of the chondroitin sulphate-
repeating units. The present study showed that chondroitin
6-sulphated linkage regions to core protein, in other word
chondroitin 6-sulphate PG revealed with antibody 3B3, was
located in the pseudocystic space of adenoid cystic carcinoma
and myxomatous areas of pleomorphic adenoma. By bio-
chemical analysis of GAG, chondroitin 6-sulphate was found
to be rich in these tumour tissues. Since chondroitin 6-
sulphate PG revealed with antibody 3B3 was detected only in
blood vessel walls in non-neoplastic tissues as reported in our
previous papers (Fukatsu et al., 1988; Sobue et al., 1987b), it
was conceivable that accumulation and/or overproduction of
chondroitin 6-sulphate PG was characteristic of adenoid cys-
tic carcinoma and pleomorphic adenoma. We reported pre-
viously (Takeuchi et al., 1975, 1976, 1978) that both tumours
contained almost the same GAG-components, and that they
had the similar activity of GAG synthesis. However, HPLC
analysis in the present study revealed that the ECM of
pleomorphic adenoma contains a relatively increased amount
of low-sulphated chondroitin sulphate than adenoid cystic
carcinoma.
Furthermore, in the present study, remarkable differences
in keratan sulphate revealed with antibody 5D4 were observ-
ed in both tumours. The ECM of pleomorphic adenoma in
all cases examined was strongly reactive for 5D4, but it was
negative in the cases of adenoid cystic carcinoma, even
though a significant amount of keratan sulphate could be
detected in both tumours by HPLC analysis. On the con-
trary, the amount of keratan sulphate of adenoid cystic
carcinoma was relatively larger (970pgg-' of dry weight)
than that of pleomorphic adenoma (330-450pggg' of dry
tissue). A reason why keratan sulphate in ECM of adenoid
cystic carcinoma was not reactive to antibody 5D4 in tissue
sections was not elucidated, but it was conceivable that the
epitope for 5D4 was blocked by some substances in ECM of
adenoid cystic carcinoma. It was also considered that the
lack of reactivity of 5D4 with keratan sulphate identified
biochemically in adenoid cystic carcinoma may be because
the amount of high-sulphated keratan sulphate is very small
since Mehmet et al. (1986) reported that the antibody 5D4
reacted mainly with high-sulphated keratan sulphate disac-
charides. Further studies to clarify the differences in re-
activity to 5D4 between both tumours should be performed.
The antibody 5D4 was raised against PG core protein after
chondroitinase ABC digestion of human articular cartilage
PG monomer, and specifically recognised an antigenic deter-
minant in the polysaccharide structure of both corneal and
skeletal keratan sulphate (Caterson et al., 1983). Keratan
sulphate could be detected by staining with 5D4 in both
non-neoplastic cartilage and cartilageous stroma of osteo-
chondrosarcoma (unpublished data in our laboratory). In the
present study, the 5D4-positive reaction was abolished by the
pre-treatment with keratanase II which digests specifically
high sulphated keratan sulphate, namely, cartilage-type.
The interesting result obtained from the present study was
that 5D4-staining was positive only in tumour tissues except
for adenoid cystic carcinoma, but not in non-neoplastic tis-
sues such as normal and inflammatory salivary gland tissues.
When ductal (tubular) epithelial cells proliferate as neoplasia,
these cells may produce a mucinous material containing
much more keratan sulphate. The ductal cells may not syn-
thesise such a mucinous material when they proliferate as a
result of an inflammatory stimulus. Acinic cell tumour also
contained 5D4-positive materials but non-neoplastic acinic
cells were not stained with 5D4. The keratan sulphate-stain-
ing with 5D4 was considered to be useful for distinguishing
neoplastic acinic cells from non-neoplastic acinic cells.
Antibody 2B1 reacts specifically with the core molecule
(MW approx. 200,000) of large PG purified from the yolk
sac tumour. Sobue et al. (1989a) have shown that the large
PG revealed with antibody 2B1 was abundant in foetal tis-
sues, but rarely observed in adult tissues in which large PG
was mainly seen in aorta and perivascular elements. Naka-
shima et al. (1990) have reported that the large PG revealed
with 2B1 is synthesised by immature mesenchymal cells and
also by epithelial-like cells as a basement membrane compo-
nent, whereas the small PG revealed with 6B6 is synthesised
by mature fibroblastic cells synthesising collagen. In the pres-
ent study, similar results were observable. The antibody 2B1-
staining was positive in the pseudocystic spaces of adenoid
cystic carcinoma, the myxomatous areas of pleomorphic ade-
noma, and the interstitial fibrous elements of mucoepider-
moid carcinoma. The positive materials in the former two
cases were considered to be a basement membrane compo-
nent, while those in the latter (so-called specific stroma) were
synthesised by the proliferating connective tissue cells (fibro-
blastic cells) which were stimulated to multiply by neoplastic
cells. Sobue et al. (1989b), having established a new cell line
from an adenoid cystic carcinoma arising in the submandi-
bular gland, showed that the adenoid cystic carcinoma cells
synthesise PG consisting mainly of chrondroitin 6-sulphate.
Table II Disaccharide-composition of GAG fraction after chondroitinase ACII-digestion (%)
1.25 M-fraction 1.60 M-fraction
Tumours A DiOS ADi 6S ADi 4S n.d. A DiOS ADi 6S ADi 4S n.d. Pleomorphic adenoma 1 4.5 82.7 11.0 1.8 3.8 69.0 19.9 7.3 Pleomorphic adenoma 2 18.4 57.8 22.1 1.7 5.3 59.3 29.8 5.6 Adenoid cystic carcinoma 1.7 80.0 14.4 3.9 1.0 77.8 16.0 5.2
Clear cell carcinoma 18.0 38.1 39.7 4.2 3.8 51.8 38.2 6.2 Oncocytoma 10.8 43.4 45.8 0.1 4.0 38.0 47.5 10.5
n.d.: not determined.
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In embryonic and tumour tissues, not only heparan sulphate
but also chondroitin sulphate and hyaluronic acid have been
demonstrated in the basement membrane (Cohn et al., 1977;
Trelstad et al., 1974). It was conceivable that the mucoid
substances appearing in the pseudocystic spaces of adenoid
cystic carcinoma and the myxomatous areas of pleomorphic
adenoma are basement membrane components which were
composed of large PG with chondroitin 6-sulphate side
chains revealed with both antibodies 2B1 and 3B3.
In the interstitial fibrous elements of mucoepidermoid car-
cinomas, the loose connective tissues was stained with 2B1
though highly collagenised tissue was reactive to 6B6. This
stainability is the same as in other carcinoma tissues (ovar-
ian, uterus, gastric, breast, and colon) as described in our
previous paper (Fukatsu et al., 1988; Sobue et al., 1989a). It
is probable that the carcinoma cells can stimulate the activity
of interstitial cells to synthesise large PG in general.
Heparan sulphate was demonstrated by staining with anti-
body HepSS-1 produced by Kure and Yoshie (1986) which
recognises specifically heparan sulphate though its epitope is
obscure. Kure and Yoshie also reported that NIH3T3
expressed more HepSS-l epitopes at low cell density than at
confluency, whereas NIH3T3 cells transformed with the
Kirsten-ras oncogene or SV-40 expressed high levels of
HepSS-1 epitopes. In the case of clear cell carcinoma, a
significant amount of heparan sulphate was detected by bio-
chemical analysis. The ratio of heparan sulphate to the other
GAG was highest in the clear cell carcinoma tissue as shown
in Figure 2, but the reactivity to HepSS-1 was observed to be
only faintly in the intercellular space or in the cell surfaces.
Since the antibody HepSS-l recognises mainly heparan sul-
phate locating on the cell surface (Kure & Yoshie, 1986), the
positive material stained with HepSS-1 may not represent all
the heparan sulphate PG contained in the tumour tissue.
The authors wish to express thanks to Chikage Yasui and Mari
Niwa for their technical assistance. This work was supported by a
grant from the Ministry of Education, Science and Culture, Japan.
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